Kidney disease

There are 900 papers on kidney disease in aging research: 17 trials and 443 observational studies in people, 86 in animals, 321 reviews. The newest story, Nov 16, 2026: “Walking-speed age patterns varied across six aging cohorts”.

Disease

900 papers study it6,281 more mention it166 findings

MeSH

722 new papers in 30 daysSee all 7,181 papers on kidney disease

At a glance

Human studies link kidney disease with dementia, sarcopenia, mortality, and higher epigenetic age in injured kidney tubular epithelial cells. A human preprint associates prematurely aged cellular compartments with kidney disease. In kdkd mice, a study reports that caloric restriction reduces kidney disease, whereas protein restriction alone shows no clear effect.

166 findings in 147 papers from 1978 to 2026, 26 of them since April 2026

“Hypertension was most strongly associated with kidney disorders in those aged 20-29 years, but with dyslipidaemia, obesity, and type 2 diabetes in individuals aged 40 years and older.”
Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based studyThe Lancet. Digital health2022doi:10.1016/s2589-7500(22)00187-x
  • Human trial17
  • Humans443
  • Animals85
  • Model organisms1
  • In silico25

Interventions

26

Caloric restriction

downin humans1downin mice1downin rats1downin Rodentia1

4 studies
  1. Caloric restriction protects against kidney disease in Rodentia (early and progressive stages of kidney disease).

    “Long-term caloric restriction executed at both early and progressive stages of kidney disease was found to exert beneficial effects in rodents.”

    Reviewearly and progressive stages of kidney diseasekidneylong-term

    Dietary restriction regimens for fighting kidney disease: Insights from rodent studies

    Experimental gerontology

  2. Caloric restriction prevents kidney disease in humans (standard level).

    “food reduction or calorie restriction to a standard level can effectively prevent and treat a variety of diseases such as neoplasms, diabetes, and kidney disease”

    Reviewstandard level

    Food Reduction in Avicenna's View and Related Principles in Classical Medicine

    Iranian Red Crescent medical journal

  3. Caloric restriction protects against kidney disease in rats.

    “Food restriction started soon after weaning or in adult life modulated most of these age changes.”

    Animalskidney

    An electron microscopic examination of age-related changes in the rat kidney: the influence of diet

    Experimental gerontology

  4. Caloric restriction decreases kidney disease in mice (kdkd mice).

    “renal disease in kdkd mice is decreased or eliminated histologically by dietary restriction”

    Animalskdkd micekidney

    Nutritional inhibition of genetically determined renal disease and autoimmunity with prolongation of life in kdkd mice

    Proceedings of the National Academy of Sciences of the United States of America

More on Caloric restriction

SGLT2 inhibitors

downin humans2downin reviews1

3 studies
  1. SGLT2 inhibitors protect against kidney disease in humans.

    “Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed as antihyperglycemic agents, have demonstrated substantial renoprotective effects”

    Review

    Application of SGLT2 inhibitors in kidney diseases: a bibliometric analysis

    Frontiers in medicine

  2. SGLT2 inhibitors protect against kidney disease in humans.

    “These drugs play a significant role in renal protection and in managing a variety of metabolic and cardiovascular disorders or risk factors.”

    Review

    Role of Sodium-Glucose Transport Protein-2 Inhibitors in Renal Protection: A Narrative Review from the Cardiovascular-Kidney-Metabolic Interconnection

    Drug design, development and therapy

  3. SGLT2 inhibitors protect against kidney disease with or without diabetes.

    “Numerous data confirmed the cardio- and -renal protective effects of SGLT-2i in patients with heart failure and kidney diseases, with or without diabetes.”

    Reviewwith or without diabetes

    The anti-inflammatory and immunological properties of SGLT-2 inhibitors

    Journal of endocrinological investigation

More on SGLT2 inhibitors

GLP-1 receptor agonists

downin humans2

2 studies
  1. GLP-1 receptor agonists protect against kidney disease in type 2 diabetes.

    “GLP1 agonists are the emerging fourth pillar of nephroprotection in type 2 diabetes (T2D)”

    Reviewin type 2 diabeteskidney

    Glucagon-like peptide 1 agonists : the fourth pillar of nephroprotection in type 2 diabetes

    Revue medicale suisse

  2. GLP-1 receptor agonists decrease kidney disease in patients with type 2 diabetes, per clinical trial data.

    “We will summarize current clinical trial data that includes reduced cardiovascular disease, kidney disease, and mortality in patients with T2DM”

    Reviewin patients with type 2 diabetes, per clinical trial data

    ASSESSING GEROTHERAPEUTIC POTENTIAL OF GLP-1 RECEPTOR AGONISTS

    GSA 2024 abstract

More on GLP-1 receptor agonists

Physical activity

no changein humans1HR 1.08

1 study
  1. Physical activity was not clearly linked with kidney disease in humans (mutually adjusted model) (HR 1.08, 95% CI 0.81–1.45).

    “1.08 (0.81–1.45) for insufficient activity”

    Humansmutually adjusted model

    Nighttime sleep duration, physical activity and newly reported doctor- diagnosed kidney disease in middle-aged and older Chinese adults: a cohort study

    Research SquarePreprint

More on Physical activity

Quercetin

downin reviews1

1 study
  1. Quercetin decreases kidney disease.

    “focuses on the powerful pharmacological effects and broad application prospects of quercetin and fisetin in kidney diseases and senescence”

    Review

    Therapeutic Application of Flavonoids in Kidney Disease and Senescence: Quercetin and Fisetin

    Integrative Medicine in Nephrology and Andrology

More on Quercetin

1,3-butanediol

downin mice1

1 study
  1. 1,3-butanediol decreases kidney disease in mice (diet-induced obesity).

    “Both interventions enhanced autophagic flux in proximal tubule cells and attenuated structural damage in glomeruli and tubules.”

    Animalsdiet-induced obesitykidney

    Dapagliflozin regulates autophagy in nephropathy associated with non-diabetic obesity via elevated plasma β-hydroxybutyrate levels

    The Biochemical journal

More on 1,3-butanediol

Dapagliflozin

downin mice1

1 study
  1. Dapagliflozin decreases kidney disease in mice (diet-induced obesity).

    “attenuated structural damage in glomeruli and tubules.”

    Animalsdiet-induced obesitykidney

    Dapagliflozin regulates autophagy in nephropathy associated with non-diabetic obesity via elevated plasma β-hydroxybutyrate levels

    The Biochemical journal

More on Dapagliflozin

Senolytics

downin reviews1

1 study
  1. Senolytics decrease kidney disease in preclinical models.

    “Therapeutic approaches targeting senescent cells, such as small molecule senolytic and senomorphic drugs, display efficacy in preclinical models.”

    Reviewin preclinical models

    Integrative Approaches to Treating Cellular Senescence in Kidney Disease

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

More on Senolytics

IL-6 inhibitors

downin humans1

1 study
  1. IL-6 inhibitors protect against kidney disease in humans (some kidney disorders).

    “IL-6 inhibition may be renoprotective in some kidney disorders”

    Reviewsome kidney disorderskidney

    Interleukin-6 in Natural and Pathophysiological Kidney Aging

    Cells

More on IL-6 inhibitors

Stem cell therapy

downin reviews1

1 study
  1. Stem cell therapy protects against kidney disease (preclinical models).

    “Evidence from preclinical models demonstrates renoprotective and immunomodulatory effects across multiple stem cell types”

    Reviewpreclinical models

    Stem cell and bioengineering approaches for end-stage renal disease: a comprehensive review

    Stem cells (Dayton, Ohio)

More on Stem cell therapy

All 26

Effects

15

Epigenetic age

upin humans1

1 study
  1. Kidney disease is linked with higher epigenetic age in diseased (injured) human kidneys.

    “tubular epithelial cells in diseased kidneys exhibit pronounced accelerated epigenetic aging”

    Humansin diseased (injured) human kidneystubular epithelial cells

    Kidney tubular epithelial cells drive accelerated epigenetic aging in disease

    Nature aging

More on Epigenetic age

Renal blood flow

downin humans1

1 study
  1. Kidney disease is linked with lower renal blood flow in humans (undergoing clinically indicated rest and stress Rb-82 MPI) (from 1.24 +/- 0.35 ml/min/g to 0.53 +/- 0.22 ml/min/g).

    “Renal K1 and flow declined progressively with worsening kidney function, from 1.24 +/- 0.35 ml/min/g (eGFR >= 60) to 0.53 +/- 0.22 ml/min/g (eGFR < 15; P < 0.0001).”

    Humansundergoing clinically indicated rest and stress Rb-82 MPIkidneyn = 126

    Renal Blood Flow Quantification During Standard Myocardial Perfusion Imaging with Rubidium-82 Positron Emission Tomography

    arXivPreprint

More on Renal blood flow

Anti-SARS-CoV-2 spike antibodies

downin humans1

1 study
  1. Kidney disease is linked with lower anti-SARS-CoV-2 spike antibodies in humans (aGMR 0.71, 95% CI 0.54-0.94, p = 0.017).

    “renal disease was associated with lower responses (aGMR 0.71, 95% CI 0.54-0.94, p = 0.017)”

    Humans6-9 months post-first boostern = 300

    Prospective Evaluation of Antibody Response post COVID-19 vaccination in older persons ≧ 60 years old (PEARL 60): A longitudinal 15-months study in a tertiary centre in Malaysia

    PloS one

More on Anti-SARS-CoV-2 spike antibodies

Cognitive decline

no changein humans1

1 study
  1. Kidney disease was not clearly linked with cognitive decline in African American adults in midlife without baseline dementia (p = .10).

    “association between mild-to-severely decreased kidney function and decline in RAVLT immediate-recall was not significant ( p = .10)”

    Humansin African American adults in midlife without baseline dementian = 130

    Plasma p ‐tau217 A+T+ status is associated with accelerated cognitive decline in the African Americans Fighting Alzheimer's in Midlife study

    AAIC 2025 abstract

P-TAU217 cutoff for amyloid-beta positivity

upin humans1

1 study
  1. Kidney disease is linked with higher P-TAU217 cutoff for amyloid-beta positivity in humans (eGFR 45–60 mL/min/1.73 m^2) (0.635 vs 0.425).

    “Specifically, optimal cutoffs for Aβ positivity were higher among individuals with eGFR <60 (0.635 for eGFR 45–60; 0.935 for eGFR <45) than among those with eGFR >60 (0.425).”

    HumanseGFR 45–60 mL/min/1.73 m^2

    Optimizing Plasma p ‐Tau217 Cutoffs for Amyloid Pathology According To Biological Factors

    AAIC 2025 abstract

More on P-TAU217 cutoff for amyloid-beta positivity

SIRT1

downin humans1

1 study
  1. Kidney disease is linked with lower SIRT1 in obese individuals with renal diseases compared to obese controls.

    “Notably, SIRT1 expression was significantly downregulated in the patient group compared to controls.”

    Humansin obese individuals with renal diseases compared to obese controlsn = 100

    SIRT1 modulation and lipid profile alterations in the cellular regulation of blood lipids in renal disorders among extremely obese individuals

    Cellular and molecular biology (Noisy-le-Grand, France)

More on SIRT1

Intrinsic capacity score

downin humans1

1 study
  1. Kidney disease is linked with lower intrinsic capacity score in humans (adjusting for demographic and socioeconomic factors) (β = -0.450, 95% CI: -0.871, -0.029, P = 0.036).

    “renal disease (-0.450, 95% CI: -0.871, -0.029, P = 0.036)”

    Humansadjusting for demographic and socioeconomic factors

    Cross-sectional analysis of factors associated with low intrinsic capacity among Malaysians ageing with HIV in ambulatory care

    AIDS (London, England)

More on Intrinsic capacity score

Longevity

downin humans1

1 study
  1. Kidney disease shortens lifespan longevity in humans.

    “Worldwide, kidney disease has grown to be an important global public health agenda that reduces longevity.”

    Review

    Application of biomarkers in the diagnosis of kidney disease

    Frontiers in medicine

Glomerular filtration rate

downin humans1

1 study
  1. Kidney disease is linked with lower glomerular filtration rate in humans (β=-40.31, P<0.001).

    “Group (K group: β=-40.31, P<0.001; NK group: β=-26.96, P<0.001), ALB (β=-0.38, P=0.038) and HbA1c (β=1.36, P=0.029) had a significant negative impact on the eGFR changes.”

    Humans

    Longitudinal Analysis of Renal Function Changes in Elderly Populations: Health Status Evaluation and Risk Factor Assessment

    Clinical interventions in aging

Hydrogen sulfide

downin humans1

1 study
  1. Kidney disease decreases hydrogen sulfide in patients with kidney disease compared with control group (SMD: -2.24; 95% CI: -4.40; -0.08).

    “or kidney disease (SMD: -2.24; 95% CI: -4.40; -0.08) compared with the control group”

    Reviewin patients with kidney disease compared with control group

    Circulating Levels of Hydrogen Sulfide (H₂S) in Patients with Age-Related Diseases: A Systematic Review and Meta-Analysis

    Biomolecules

More on Hydrogen sulfide

All 15

Upstream

9

Telomere length

no changein humans1

1 study
  1. Telomere length was not clearly linked with kidney disease in humans (Mendelian randomisation).

    “Mendelian randomisation highlighting no significant association between genetically predicted telomere length and kidney disease.”

    HumansMendelian randomisation

    Differential Methylation of Telomere-Related Genes Is Associated with Kidney Disease in Individuals with Type 1 Diabetes

    Genes

More on Telomere length

ACE2

downin rats1

1 study
  1. ACE2 protects against kidney disease in rats (ageing).

    “vascular ACE2-overexpression protects the kidney against ageing-induced decline in kidney function”

    Animalsageingkidney

    Transgenic angiotensin-converting enzyme 2 overexpression in the rat vasculature protects kidneys from ageing-induced injury

    Kidney international

More on ACE2

DDX58

upin mice1

1 study
  1. DDX58 increases kidney disease in mice (shown by knockout, cisplatin-induced kidney injury).

    “Male mice with RIG-I knock-out (KO) are protected from cisplatin-induced kidney disease.”

    Animalsshown by knockout, cisplatin-induced kidney injurykidneymales

    NAD⁺ precursor supplementation prevents mtRNA/RIG-I-dependent inflammation during kidney injury

    Nature metabolism

More on DDX58

GPER1

downin reviews1

1 study
  1. GPER1 protects against kidney disease (experimental animal models).

    “GPER1 has been shown to be protective against CV and renal diseases in different experimental animal models.”

    Reviewexperimental animal models

    Emerging Roles for G Protein-Coupled Estrogen Receptor 1 in Cardio-Renal Health: Implications for Aging

    Biomolecules

More on GPER1

Klotho

downin reviews1

1 study
  1. Klotho protects against kidney disease (exogenous supplementation or overexpression of endogenous Klotho).

    “exogenous supplementation or overexpression of endogenous Klotho attenuates kidney disease”

    Reviewexogenous supplementation or overexpression of endogenous Klothokidney

    Epigenetic and non-epigenetic regulation of Klotho in kidney disease

    Life sciences

More on Klotho

Sirtuin signaling

downin reviews1

1 study
  1. Sirtuin signaling protects against kidney disease.

    “The available evidence indicates that sirtuins have great potential as novel therapeutic targets for the prevention and treatment of kidney diseases.”

    Review

    The Role of Sirtuins in Kidney Diseases

    International journal of molecular sciences

More on Sirtuin signaling

Cellular senescence

downin reviews1

1 study
  1. Cellular senescence protects against kidney disease during development and in some models of renal diseases.

    “cellular senescence may be renoprotective during development and in some models of renal diseases”

    Reviewduring development and in some models of renal diseaseskidney

    Cellular Senescence: A New Player in Kidney Injury

    Hypertension (Dallas, Tex. : 1979)

More on Cellular senescence

Autophagy

downin reviews1

1 study
  1. Autophagy protects against kidney disease.

    “autophagy protects kidney from versatile kidney inflammatory insults, including those that are acute, chronic, metabolic, and aging-related”

    Reviewkidney

    Autophagy and kidney inflammation

    Autophagy

More on Autophagy

PRKAR2B

downin mice1

1 study
  1. PRKAR2B decreases kidney disease in mice (RIIbeta(-/-) vs WT).

    “decreased severity of renal lesions, and a trend towards a decrease in age-related cardiac pathology.”

    AnimalsRIIbeta(-/-) vs WTmales

    Disruption of protein kinase A in mice enhances healthy aging

    PloS one

More on PRKAR2B

Associations

93

Mortality

upin humans13HR 1.248–2.29

13 studies
  1. Kidney disease is associated with mortality in humans (hypertensive renal disease) (AAPC: 8.83%).

    “hypertensive heart disease (AAPC: 4.35%) and renal disease (AAPC: 8.83%) surged.”

    Humanshypertensive renal disease2000 to 2024

    Temporal Trends and Demographic Disparities in Mortality Due to Coronary Artery Disease and Hypertension in Adults Aged 25 and Above in the United States (2000 to 2024)

    Clinical cardiology

  2. Kidney disease is linked with a higher risk of mortality in humans (undergoing primary total hip arthroplasty) (HR = 2.29; 95% CI = 2.1-2.5).

    “renal disease (HR = 2.29; 95% CI = 2.1-2.5)”

    Humansundergoing primary total hip arthroplasty

    Perioperative risk factor analysis for mortality in patients undergoing total hip arthroplasty: A national database study from Türkiye

    Acta orthopaedica et traumatologica turcica

  3. Kidney disease is associated with mortality in bullous pemphigoid patients (HR 1.62, 95% CI: 1.13-2.32).

    “and increased mortality (hazard ratio 1.62, 95% CI: 1.13-2.32).”

    Humansin bullous pemphigoid patientsn = 45,323

    Chronic disease associated with bullous pemphigoid risk: A systematic review and meta-analysis

    JAAD international

  4. Kidney disease is linked with a higher risk of mortality in humans after hip fracture surgery (OR 1.958, 95% CI 1.014-3.784, p = 0.045).

    “history of renal disease (OR = 1.958; 95% CI 1.014-3.784; p = 0.045)”

    Humansafter hip fracture surgery

    Preoperative hemoglobin levels and mortality outcomes after hip fracture patients

    BMC surgery

  5. Kidney disease is associated with mortality in humans (type 2 diabetes mellitus) (HR: 2.17).

    “vascular (HR: 2.15), and kidney (HR: 2.17) diseases were independently associated with death.”

    Humanstype 2 diabetes mellitus13 yearsn = 107

    The multidimensional prognostic index (MPI) predicts long-term mortality in old type 2 diabetes mellitus patients: a 13-year follow-up study

    Journal of endocrinological investigation

  6. Kidney disease is associated with mortality in humans (52.3% vs. 24.1%, p = 0.008).

    “Immobility (97.7% vs. 77.8%, p = 0.005) and renal disease (52.3% vs. 24.1%, p = 0.008) were more often found in patients who died.”

    Humansn = 98

    Individuals Who Developed Delirium While Enrolled in the Hospital Elder Life Program: An Exploratory Study

    Journal of gerontological nursing

  7. Kidney disease is linked with a higher risk of mortality in humans (regardless of age group).

    “Regardless of age group, the presence of neurological disease, renal disease, liver disease, and cancer was associated with an increased risk of mortality.”

    Humansregardless of age group

    Comorbidities associated with COVID-19 mortality in adults in Lima, Peru: a retrospective cohort study

    Revista peruana de medicina experimental y salud publica

  8. Kidney disease is linked with a higher risk of mortality in humans following osteoporotic hip fracture (HR=1.248; 95% CI, 1.040-1.497).

    “The incidence and mortality of fractures increased when there were increasing age, more than three underlying diseases (HR=1.945; 95% CI, 1.284-2.945), cerebrovascular diseases (HR=1.429; 95% CI, 1.232-1.657), and renal diseases (HR=1.248; 95% CI, 1.040-1.497).”

    Humansfollowing osteoporotic hip fracture

    Analyzing the Risk Factors of Mortality after Osteoporotic Hip Fractures Using the National Health Insurance Service Sample Cohort 2.0 Database

    Hip & pelvis

  9. Kidney disease is linked with a higher risk of mortality in hip fracture patients with COVID-19 (HR 1.53, p = 0.017).

    “renal disease (HR 1.53, p = 0.017), and pulmonary disease (HR 1.45, p = 0.039) were independently associated with a higher 30-day mortality risk in patients with COVID-19”

    Humansin hip fracture patients with COVID-19

    IMPACT-Global Hip Fracture Audit: Nosocomial infection, risk prediction and prognostication, minimum reporting standards and global collaborative audit: Lessons from an international multicentre study of 7,090 patients conducted in 14 nations during the COVID-19 pandemic

    The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland

  10. Kidney disease is associated with mortality in humans (twice as high).

    “Five-year and ten-year mortality rates were twice as high in patients with kidney disease compared with the general population.”

    Humans5 to 10 years

    Kidney disease and risk of dementia: a Danish nationwide cohort study

    BMJ open

All 13

Hypertension

upin humans3

3 studies
  1. Kidney disease is linked with a higher risk of hypertension in humans (PR = 2.05).

    “In multivariable analyses, hypertension was significantly associated with older age, kidney disease (PR = 2.05), obesity (PR = 1.72), dyslipidemia (PR = 1.57), diabetes (PR = 1.34), and ever smoking (PR = 1.19).”

    Humans

    Prevalence and risk factors of hypertension in Saudi Arabia based on a nationally representative survey

    Frontiers in cardiovascular medicine

  2. Hypertension is associated with kidney disease in those aged 20-29 years.

    “Hypertension was most strongly associated with kidney disorders in those aged 20-29 years, but with dyslipidaemia, obesity, and type 2 diabetes in individuals aged 40 years and older.”

    Humansin those aged 20-29 years

    Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study

    The Lancet. Digital health

  3. Hypertension is linked with a higher risk of kidney disease in humans (normal kidney function at baseline).

    “Multivariate analysis found advanced age, female, elevated baseline SUA, elevated SUA change, hypertension and triglyceride-glucose index were risk factors for rapid eGFR decline and new-onset kidney disease.”

    Humansnormal kidney function at baselinekidney5 yearsn = 2,436

    A follow-up study to explore factors associated with rapid kidney function decline and new-onset kidney disease among Chinese elderly population

    Geriatrics & gerontology international

More on Hypertension

SGLT2 inhibitors

downin humans1downin silico1

2 studies
  1. SGLT2 inhibitors lower the risk of kidney disease in humans.

    “SGLT2 inhibitors showed particularly consistent benefit for heart failure and kidney outcomes”

    Review

    Cardiorenal Protection in Type 2 Diabetes: A Systematic Review Comparing Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors

    Cureus

  2. SGLT2 inhibitors lower the risk of kidney disease in silico (compared with baseline treatment).

    “Compared with baseline treatment, SGLT2i and GLP-1 RA reduced lifetime rates of cardiovascular and renal events”

    In silicocompared with baseline treatment

    Cost-effectiveness of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists for patients with high cardiovascular risk and type 2 diabetes in Canada

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

More on SGLT2 inhibitors

GLP-1 receptor agonists

downin humans1downin silico1

2 studies
  1. GLP-1 receptor agonists are linked with a lower risk of kidney disease in patients with diabetes and prior MALEs (SHR 0.61, 95% CI 0.54-0.70).

    “progression to dialysis (SHR, 0.61; 95% CI, 0.54-0.70)”

    Humansin patients with diabetes and prior MALEsn = 17,288

    Glucagon-Like Peptide-1 Receptor Agonists and Prior Major Adverse Limb Events in Patients With Diabetes

    JAMA network open

  2. GLP-1 receptor agonists lower the risk of kidney disease in silico (compared with baseline treatment).

    “Compared with baseline treatment, SGLT2i and GLP-1 RA reduced lifetime rates of cardiovascular and renal events”

    In silicocompared with baseline treatment

    Cost-effectiveness of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists for patients with high cardiovascular risk and type 2 diabetes in Canada

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

More on GLP-1 receptor agonists

Cellular senescence

upin reviews2

2 studies
  1. Cellular senescence is associated with kidney disease.

    “cellular senescence plays an important role in the pathogenesis of different forms of renal damage, including acute and chronic kidney disease, and renal transplantation”

    Reviewkidney

    Cellular Senescence: A New Player in Kidney Injury

    Hypertension (Dallas, Tex. : 1979)

  2. Cellular senescence is associated with kidney disease (through the senescence-associated secretory phenotype (SASP)).

    “it is also involved in many cardiovascular, renal and liver diseases through the senescence-associated secretory phenotype (SASP)”

    Reviewthrough the senescence-associated secretory phenotype (SASP)

    The emerging role of cellular senescence in renal diseases

    Journal of cellular and molecular medicine

More on Cellular senescence

Type 2 diabetes

upin humans1

1 study
  1. Type 2 diabetes raises the risk of kidney disease in humans (Ratio 3.14).

    “Type 2 diabetes raises later risk of kidney disease (3.14)”

    Review

    Type 2 Diabetes, Metformin and Prediabetes: A Results Sheet of What Raises Risk, What Lowers Blood Sugar and What People Search

    Research SquarePreprint

More on Type 2 diabetes

Lithium

downin humans1OR 0.49–0.93

1 study
  1. Lithium is associated with kidney disease in humans (Residents of rural US counties) (Adjusted ORs 0.49–0.93).

    “functional impairment (adjusted ORs ranged from 0.33 to 0.87), and kidney disease diagnosis (adjusted ORs ranged from 0.49 to 0.93)”

    HumansResidents of rural US countiesGroundwater lithium ≥30 μg/L versus <10 μg/L

    Groundwater Lithium Availability Association with Physical and Mental Health Outcomes in United States Populations

    Research SquarePreprint

More on Lithium

Tricyclic antidepressants

upin humans1OR 1.91

1 study
  1. Tricyclic antidepressants are associated with kidney disease in humans (patients with bipolar disorder) (OR 1.91, 95% CI 1.32–2.77).

    “the largest elevations for TCAs were observed for cardiac arrhythmias (OR = 2.55, 95% CI 1.98–3.28), renal disease (OR = 1.91, 95% CI 1.32–2.77)”

    Humanspatients with bipolar disorder

    From prescription to prognosis: longitudinal associations between different antidepressant classes on medical comorbidity in those with bipolar disorder

    International journal of bipolar disorders

More on Tricyclic antidepressants

Premature organelle aging

upin humans1

1 study
  1. Premature organelle aging is associated with kidney disease in humans (Four or more prematurely aged compartments) (Up to 22-fold higher kidney disease risk).

    “Individuals with four or more prematurely aged compartments exhibited up to 22-fold higher kidney disease risk and up to 8-fold higher mortality risk.”

    HumansFour or more prematurely aged compartmentsn = 61,931

    Measures of aging in cell structures linked to disease risk

    bioRxivPreprint

More on Premature organelle aging

Gait speed

mixedin humans1

1 study
  1. Kidney disease is associated with gait speed in humans (HAALSI, in M2–M4 analyses).

    “M2–M4 identified additional cohort-specific associations with cognition and kidney disease most informative in HAALSI, and IADL items contributed in intermediate-functioning cohorts.”

    HumansHAALSI, in M2–M4 analyses

    Walking-speed age patterns varied across six aging cohorts

    Archives of gerontology and geriatrics

All 93

Trial sponsors

Funding

245 grants since 2016

National Institute of Diabetes and Digestive and Kidney Diseases$91.8MNational Institute on Aging$28.7MJapan Society for the Promotion of Science¥258M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    A human screening study identifies kidney disease in 31.7% of participants at HIV and COVID-19 vaccine clinics; another human study links kidney disease to increased kidney epigenetic age.

  2. Summary written from the findings.

Latest

Archives of Gerontology and Geriatrics

Walking-speed age patterns varied across six aging cohorts

The modeled walking-speed transition midpoint was 82.44 years in the UK cohort versus 56.70 years in South Africa, where the estimate extended beyond observed ages.The modeled walking-speed transition midpoint was 82.44 years in the UK cohort versus 56.70 years in South Africa, where the estimate extended beyond observed ages.

Cross-sectional studyPopulations

See all 7,181 papers on kidney disease